New infrastructure $ for Canada

The Canada Foundation for Innovation (CFI), an independent organization established by the government in 1997 to fund research infrastructure, announced a new C$45.5 million ($38.2USD million) program last month aimed at providing equipment and attracting researchers to Canadian institutions. The scheme will jump start 251 projects across 44 universities under two funds: C$38.2 million ($32.1USD million) was awarded under the Leaders Opportunity Fund -- a scheme for universities to buy equipmen

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The Canada Foundation for Innovation (CFI), an independent organization established by the government in 1997 to fund research infrastructure, announced a new C$45.5 million ($38.2USD million) program last month aimed at providing equipment and attracting researchers to Canadian institutions. The scheme will jump start 251 projects across 44 universities under two funds: C$38.2 million ($32.1USD million) was awarded under the Leaders Opportunity Fund -- a scheme for universities to buy equipment, buildings, and databases -- and the remaining C$7.2 million ($6.0USD million) under the Infrastructure Operating Fund, an accompanying program to cover maintenance and operational costs.
"Investing in cutting-edge labs, equipment, and technology has transformed Canada's research landscape over the past decade," said linkurl:Eliot Phillipson,;http://www.innovation.ca/en/about-the-cfi/staff/biography-eliot-phillipson the CFI's president and CEO, in a linkurl:press release.;http://www.innovation.ca/en/news?news_id=18 "The CFI keeps pace with this transformation to ensure Canadian research institutions and their researchers remain world class." To put this funding in perspective, the new CFI investment is on par with the annual budget increases of the linkurl:Canadian Institutes of Health Research;http://www.cihr-irsc.gc.ca/ and the linkurl:Natural Sciences and Engineering Research Council,;http://nserc.ca/ the country's largest research funding bodies. The total 2008-09 budgets of the CIHR and NSERC were C$831 million ($695USD million) and C$999 million ($835USD million), respectively. The University of Toronto was the biggest winner, receiving C$4.7 million ($4.0USD million) for more than 20 projects, including studies of metabolomics, plant evolutionary genomics, and mapping genetic interactions. The University of Montreal pulled in C$3.9 million ($3.3USD million) to investigate HIV-host cell interactions, whole genome population genetics, multi-protein complexes, and RNA engineering. Queen's University in Kingston, Ontario, was awarded C$2.1 million ($1.8USD million) for several projects including studies of gastrointestinal disease, tissue engineering, and biodiversity. A full list of the institutes and projects that received funding under the scheme is available on the linkurl:CFI website.;http://www.innovation.ca/en/news?news_id=18
**__Related stories:__***linkurl:Oh, Canada!;http://www.the-scientist.com/article/display/15054/
[8th November 2004]*linkurl:More funds for Canada science;http://www.the-scientist.com/article/display/22070/
[24th March 2004]*linkurl:Canadian researchers cheer new funding;http://www.the-scientist.com/article/display/21129/
[20th February 2003]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies